Novel nonpeptidic inhibitors of HIV-1 protease obtained via a new multicomponent chemistry strategy

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 12, 2004, Pages 3121-3125

  Yehia, Nasser A M ^a   Antuch, Walfrido ^a   Beck, Barbara ^a   Hess, Sibylle ^a   Schauer Vukašinović, Vesna ^a   Almstetter, Michael ^a   Furer, Patrick ^a   Herdtweck, Eberhardt ^b   Dömling, Alexander ^a  

^a Biovertis AG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

AIDS; HIV; Inhibitor; Isocyanide; MCR; Protease

Indexed keywords

PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; X RAY ANALYSIS;

BINDING SITES; CHEMISTRY, PHARMACEUTICAL; HIV PROTEASE; HIV PROTEASE INHIBITORS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 2442621127     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.04.026     Document Type: Article

References (29)

1. Wlodawer A., Miller M., Jaskolski M., Sathyanarayana B.K., Baldwin E., Weber I.T., Selk L.M., Clawson L., Schneider J., Kent S.B. Science. 245:1989;616
2. Roberts N.A., Martin J.A., Kinchington D., Broadhurst A.V., Craig J.C., Duncan I.B., Galpin S.A., Handa B.K., Kay J., Kröhn A., Lambert R.W., Merett J.H., Mills J.S., Parkes K.E.B., Redshaw S., Ritchie A.J., Taylor D.L., Thomas G.J., Machin P.J. Science. 248:1990;358
3. Robinson B.S., Riccardi K.A., Gong Y., Guo Q., Stock D.A., Blair W.S., Terry B.J., Deminie C.A., Djang F., Colonno R.J., Lin P. Antimicrob. Agents Chemother. 44:1996;292
4. Sham H.L., Kempf D.J., Molla A., Marsh K.C., Kumar G.N., Chen C., Kati W., Stewart K., Lal R., Hsu A., Betebenner D., Korneyeva M., Vasavanonda S., McDonald E., Saldivar A., Wideburg N., Chen X., Niu P., Park C., Jayanti V., Grabowski B., Granneman G.R., Sun E., Japour A.J., Leonard J.M., Plattner J.J., Norbeck D.W. Antimicrob. Agents Chemother. 42:1998;3218
5. Kim E.E., Baker C.T., Dwyer M.D., Murcko M.A., Rao B.G., Tung R.D., Navia M.A. J. Am. Chem. Soc. 117:1995;1181
6. Vacca J.P., Dorsey B.D., Schleif W.A., Levin R.B., McDaniel S.L., Darke P.L., Zugay J., Quintero J.C., Blahy O.M., Roth E., Sardana V.V., Schlabach A.J., Graham P.I., Condra J.H., Gotlib L., Holloway M.K., Lin J., Chen I.-W., Vastag K., Ostovich D., Anderson P.S., Emini E.A., Huff J.R. Proc. Natl. Acad. Sci. U.S.A. 91:1994;4096
7. Patick A.K., Ho H., Markowitz M., Appelt K., Wu B., Musick L., Kaldor S., Reich S., Ho D., Webber S. Antimicrob. Agents Chemother. 40:1996;292
8. Kempf D.J., Marsh K.C., Denissen J., McDonald E., Vasavanonda S., Flentge C., Green B.G., Fino L., Park C., Kong X., Wideburg N.E., Saldivar A., Ruiz L., Kati W.M., Sham H.L., Robins T., Stewart K.D., Plattner J.J., Leonard J., Norbeck D. Proc. Natl. Acad. Sci. U.S.A. 92:1995;2484
9. Poppe S.M., Slade D.E., Chong K.-T., Hinshaw R.R., Pagano P.J., Markowitz M., Ho D.D., Mo H., Gorman R.R. III, Dueweke T.J., Thaisrivongs S., Tarpley W.G. Antimicrob. Agents Chemother. 41:1997;1058
10. Condra J.H., Schleif W.A., Blahy O.M., Gabryelski L.J., Graham D.J., Quintero J.C., Rhodes A., Robbins H.L., Roth E., Shivaprakash M., Titus D., Yang T., Teppler H., Squires K.E., Deutsch P.J., Emini E.A. Nature. 374:1995;569
11. Hardly any HIV-PI is synthesized below 15 steps
12. Dömling A., Ugi I. Angew. Chem., Int. Ed. 39:2000;3169
13. Passerini M. Gazz. Chim. Ital. 51:1921;126
14. Dieckmann W. Chem. Ber. 27:1894;965
15. Step I. Passerini product: 1 equiv 2-substituted acetic acid derivative (5 mmol) were added to a stirred solution of 1 equiv α-ketoester (5 mmol) in 5 mL THF at room temperature. After 5 min, 1 equiv isocyanide was added and allowed to stir 24-48 h. The reaction mixture was then concentrated in vacuum. The residue was purified by silica gel chromatography, recrystallized from ethyl acetate/n-pentane, or by prep. HPLC to give an oil or a solid.
16. Thaisrivongs S., Tomich P.K., Watenpaugh K.D., Chong K.T., Howe W.J., Yang C.-P., Strohbach J.W., Turner S.R., McGrath J.P., Bohanon M.J., Lynn J.C., Mulichak A.M., Spinelli P.A., Hinshaw R.R., Pagano P.J., Moon J.B., Ruwart M.J., Wilkinson K.F., Rush B.D., Zipp G.L., Dalga R.J., Schwende F.J., Howard G.M., Padbury G.E., Toth L.N., Zhao Z., Koeplinger K.A., Kakuk T.J., Cole S.L., Zaya R.M., Piper R.C., Jeffrey P. J. Med. Chem. 37:1994;3200
17. Hagen S.E., Vara Prasad J.V.N., Boyer F.E., Domagala J.M., Ellsworth E.L., Gajda C., Hamilton H.W., Markoski L.J., Steinbaugh B.A., Tait B.D., Lunney E.A., Tummino P.J., Ferguson D., Hupe D., Nouhan C., Graceck S.J., Saunders J.M., VanderRoest S. J. Med. Chem. 40:1997;3707
18. Moloc, ; Paul Gerber. Gerber Molecular Design, http://www.moloc.ch
19. Miller M., Schneider J., Sathyanarayana B.K., Toth M.V., Marshall G.R., Clawson L., Selk L., Kent S.B.H., Wlodawer A. Science. 246:1989;1149
20. -1. Crystallographic data (excluding structure factors) for the structure reported in this paper have been deposited with the Cambridge Crystallographic Data Center as supplementary publication no CCDC-235266 (12). Copies of the data can be obtained free of charge on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK (fax: +44-1223-336-033; e-mail: deposit@ccdc.cam.ac.uk)
21. (b) Data Collection Software for Nonius kappa-CCD devices, Delft (The Netherlands), 2001
22. Otwinowski Z., Minor W. Carter W.C. Jr., Sweet R.M. Methods in Enzymology. Vol. 276:1997;307-326 Academic, New York
23. SIR92: Altomare A., Cascarano G., Giacovazzo C., Guagliardi A., Burla M.C., Polidori G., Camalli M. J. Appl. Crystallogr. 27:1994;435
24. Spek A.L. PLATON. 2001;Utrecht University, Utrecht (The Netherlands)
25. +
26. 50 of the inhibitor by using the program Grafit (Erythacus, England)
27. Cornish-Bowden A. Biochem. J. 137:1974;143
28. Yurek D.A., Branch D.L., Kuo M.S. J. Comb. Chem. 4:2002;138
29. Koradi R., Billeter M., Wüthrich K. J. Mol. Graphics. 14:1996;51